It may be that TF-EVs only promote VTE in patients with tumors that dramatically overexpress TF, such as pancreatic cancer, but to our knowledge such inter-cancer type analysis on associations between TF expression and risk of VTE has never been performed. The gene discussed is TF; the disease is pancreatic neoplasm.